Search
healthcare › ... › endoscopy
… All patients will be informed at the time of their visit of the potential need for an endoscopic evaluation, …
healthcare › clinical-trials › h-39398
… diaphragmatic hernia 2. Fetuses presenting at the latest at 31 weeks plus 5 days gestation (intervention at the latest on 31 weeks plus 6 days) 3. Severity: Predicted … at the latest the day before occlusion, but ideally between 26 and 31 weeks for practical reasons. (The O/E LHR is a …
education › school-of-medicine › graduate-medical-education
… medical city in the world, averages 8 million patients visits per year and 9,200 total patient beds. … Visit the following links to view resources provided to our …
healthcare › ... › prosthetic-replacement-of-the-ocular-surface-ecosystem-prose
… Fellow to assess candidacy. PROSE treatment (5-10 day-long visits). Periodic follow-up visits as required during the first 6 months. Annual …
departments › ... › faculty
… Aaron Cox, Ph.D., BMSc Adjunct Assistant Professor Marco …
about-us › ... › expanding-our-role-in-promoting-trust-in-science-for-covid-19-vaccine-acceptance-and-beyond
… American culture and the communities in which they live. Unfortunately, confidence in both science and public … vaccine if offered, citing mistrust as a major reason for vaccine hesitancy . Another challenge is ensuring that people who got their first dose of vaccine come back for the second and aren’t dissuaded by misinformation or …
healthcare › clinical-trials › h-42584
… concurrently with definitive regional radiotherapy for treatment of cervical cancer. … Study of niraparib with radiotherapy for treatment of metastatic invasive carcinoma of the cervix …
healthcare › clinical-trials › h-49648
… GEKO as an adjunct for the treatment of lower extremity edema in acute heart …
healthcare › clinical-trials › h-46767
… and evaluate genomic biomarkers found in menstrual fluid for the development of a non-invasive diagnostic test for uterine disorders such as endometriosis and adenomyosis, … staging and classification of disease. A non-invasive test for uterine disorders would fundamentally change how these …
news › tumor-induced-b-cell-changes-reveal-potential-biomarker-for-treatment-response-in-triple-negative-breast-cancer
… B cell abnormalities that could serve as blood biomarkers for determining likelihood of response to standard-of-care … TiBA-1, has a reduced number of B cells, likely due to competition with myeloid progenitors in the bone marrow … In a study of 35 patients, 78.6% of TiBA-0 patients had a complete response to treatment with chemotherapy and …